Business
- Dengue Vaccine Market : An Overview
18 Nov, 2024 - Meiji Seika Pharma invests in ARCALIS to boost production of mRNA vaccines in Japan
18 Nov, 2024 - Mpox Vaccine Production Reaches 10 Million Doses
16 Nov, 2024 - VBI Vaccines Issues Voluntary Nationwide Recall of all PreHevbrio Vaccine Due to Discontinuation of Company Operations
15 Nov, 2024 - Vaccine stocks sag in US, Europe after RFK Jr.’s HHS appointment
15 Nov, 2024 - Bavarian Nordic has $340 mln orders for its mpox, smallpox vaccine in 2025
15 Nov, 2024 - Vaccines Market: Growing Prevalence of Viral Infectious Diseases to Drive a 3.70% CAGR through 2031
14 Nov, 2024 - Pneumonia Vaccine Market Poised for Significant Expansion: Projected to Achieve $28 Billion by 2031 with a Robust 7.2% CAGR – Market Research Intellect
14 Nov, 2024 - Influenza Vaccine Market Growth Analysis | 7.6% CAGR By 2033
14 Nov, 2024 - Vaxart Inc (VXRT) Q3 2024 Earnings Call Highlights: Advancements in Oral Vaccine Platform
14 Nov, 2024 - New partnership to advance cervical cancer elimination efforts in PNG
14 Nov, 2024 - Vaxart’s Q3 2024: Progress in Oral Vaccine Development
14 Nov, 2024 - Valneva Engages Investors with Promising Vaccine Developments
13 Nov, 2024 - Tonix Pharma Reveals Promising TNX-801 Vaccine Data
13 Nov, 2024 - Toxoid Vaccine Market Size, Share 2024, Impressive Industry Growth Report 2031
13 Nov, 2024 - Stock Watch: Q3, Bonfire Of The Vaccine Manufacturers
13 Nov, 2024 - Asia Pacific Preventive Vaccines Market Size, Share And Trends | $63.11 billion by 2032
13 Nov, 2024 - Preventive Vaccine Market: Company Profiles, Segment Size,
13 Nov, 2024 - Novavax Advances Vaccine Strategy Amid Financial Shifts
13 Nov, 2024 - Protein-based Vaccine Sales Strategy Advances
13 Nov, 2024 - Russia says African, ex-Soviet countries interested in its mpox vaccine
13 Nov, 2024 - Novavax Stock is Slipping After the Vaccine Maker Cut its Outlook Again
12 Nov, 2024 - IO Biotech reports Q3 EPS (36c), consensus (29c)
12 Nov, 2024 - Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
12 Nov, 2024 - GeoVax Reports Third Quarter 2024 Financial Results and Provides Business Update
12 Nov, 2024 - Self Amplifying RNA Vaccines Patent Landscape and Forecast
12 Nov, 2024 - Human Papillomavirus (HPV) Vaccines Market To Show Startling Growth During Forecast Period 2024-2032
11 Nov, 2024 - Moderna Sees Revenue Plummet by 44% through September, But Cuts Losses
11 Nov, 2024 - Meningococcal Vaccines Market Size Expected to Hit USD 6.35 Billion by 2032, Expanding at a 6.5% CAGR: VMR
11 Nov, 2024
0 Comments